Cristoforo Silvestri received a Bachelor’s degree in Genetics from York University in Toronto in 1998, and pursued graduate studies at the Institute of Medical Sciences of the University of Toronto where he received his PhD in 2009. From 2009 to 2014, he completed a postdoctoral fellowship with Dr. Vincenzo Di Marzo at the Institute of Biomolecular Chemistry of the National Research Council in Italy on endocannabinoids (and related compounds) and phytocannabinoids in obesity and associated metabolic disorders.
Since 2017, Dr. Silvestri has been an Assistant Professor in the Faculty of Medicine at Université Laval. Furthermore, he holds the Sentinel North partnership research chair on the gut microbiome-endocannabinoid system as an integrator of extreme environmental influences on bioenergetics.
Dr. Silvestri has extensive experience in collaborating with world-renowned pharmaceutical industries in the field of intestinal microbiota and endocannabinoids. He has also been involved in a number of collaborations with institutes associated with Université Laval (i.e. INAF and CERVO) on projects ranging from neuronal development and behaviour to the metabolic benefits of probiotics.
His laboratory is located at the Quebec Heart and Lung Institute and focuses on the molecular and cellular actions of the endocannabinoid system on metabolism.
- Québec, Canada
- Article Feed
- Joined
